Therapeutic Potential of Gum Arabic (Acacia senegal) in Chronic Kidney Disease Management: A Narrative Review
- PMID: 39407837
- PMCID: PMC11477033
- DOI: 10.3390/jcm13195778
Therapeutic Potential of Gum Arabic (Acacia senegal) in Chronic Kidney Disease Management: A Narrative Review
Abstract
Chronic kidney disease (CKD) poses significant health challenges globally, particularly in regions like the Middle East. This review evaluates the potential efficacy and safety of Gum Arabic (Acacia senegal), a traditional remedy, in managing CKD. A comprehensive literature review was conducted using databases including PubMed and Scopus, focusing on the biochemical, physiological, and therapeutic impacts of Gum Arabic on renal health. Gum Arabic has demonstrated antioxidative and anti-inflammatory properties that may benefit renal function, as shown in animal studies. Clinical trials suggest improvements in renal biomarkers, though these are limited by scope and methodology. While promising, the clinical application of Gum Arabic requires cautious interpretation due to gaps in understanding its mechanisms of action. Gum Arabic shows potential as an adjunct treatment for CKD, reflecting both traditional use and preliminary scientific evidence. Future research should focus on its long-term efficacy, safety, and underlying biochemical pathways to better guide its therapeutic use.
Keywords: Acacia senegal; chronic kidney disease; gum arabic; renal health; traditional medicine.
Conflict of interest statement
The author declares no conflict of interest.
Figures
References
-
- Phillips G.O., Ogasawara T., Ushida K. The regulatory and scientific approach to defining gum arabic (Acacia senegal and Acacia seyal) as a dietary fibre. Food Hydrocoll. 2008;22:24–35. doi: 10.1016/j.foodhyd.2006.12.016. - DOI
-
- Jarrar A.H., Stojanovska L., Apostolopoulos V., Feehan J., Bataineh M.F., Ismail L.C., Al Dhaheri A.S. The effect of gum arabic (Acacia senegal) on cardiovascular risk factors and gastrointestinal symptoms in adults at risk of metabolic syndrome: A randomized clinical trial. Nutrients. 2021;13:194. doi: 10.3390/nu13010194. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources